day 1 agenda
| Day -1 (Sept 20, 2022) | |
| 08:00 - 09:00 | Registrations |
| 09:00 - 09:15 | Opening Ceremony & Moderator Speech |
| 09:15- 09:45 | Title: Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer |
| Yu Dihua,The University of Texas MD Anderson Cancer Center, USA | |
| 09:45- 10:15 | Title: Mutant ESR1 Receptors Cooperate with the Androgen receptor to drive metastatic progression |
| Suzanne A. W. Fuqua, Baylor College of Medicine, USA | |
| 10:15- 10:45 | Title: Immunological targeting of the oncogene tMUC1 leads to significant anti-tumor effects in breast cancer |
| Pinku Mukherjee, UNC Charlotte, USA | |
| 10:45 - 11:00 | Group Photo & Refreshment Break |
| Morning Session: Breast Cancer Screening & Diagnosis | |
| Session Chairs: Suzanne A. W. Fuqua, Baylor College of Medicine, USA |
|
| 11:00 - 11:20 | Title: Quantitative Fluorescence Polarization Optical Cytology of Breast Cancer |
| Anna N Yaroslavsky, University of Massachusetts, USA | |
| 11:20 - 11:40 | Title: Breast Cancer Awareness Among Afghan Refugee Women |
| Mutlay Sayan, Harvard University, USA | |
| 11:40-12:00 | Title: Impact of COVID-19 and Socioeconomic Factors on Delays in High-Risk MRI Breast Cancer Screening |
| Helena Teng, McMaster University, Canada | |
| 12:00-12:20 | Title: A bioinformatics analysis to investigate long non-coding RNAs mediated gene regulation in human breast invasive carcinoma |
| Giulia Fiscon, Sapienza University of Rome, Italy | |
| 12:20-12:40 | Title: HER2-Low Breast Cancers: New opportunities and Challenges |
| Huina Zhang, University of Rochester Medical Center, USA | |
| 12:40-13:00 | Title: Minimal Invasive Complete Duct Excision With Ultrasound-Guided Vacuum-Assisted Breast Biopsy: A Novel Technique For Pathological Nipple Discharge |
| Yinguang GAO, Capital Medical University, China | |
| 13:00-14:00 | Lunch Break |
| Session: Breast Caner Research & Treatment | |
| Session Chairs: Huina Zhang, University of Rochester Medical Center, USA Charles V. Clevenger, |
|
| 14:00-14:20 | Title: Novel pathogenic variants in PALB2 and BARD1 genes that associated with ER+ breast cancer in Saudi Population |
| Yousef MohammedRabaa Hawsawi, King Faisal Specialist Hospital and Research Centre, saudi arabia | |
| 14:20 - 14:40 | Title: IN SILICO RECOGNITION OF A PROGNOSTIC SIGNATURE IN BASAL-LIKE BREAST CANCER PATIENTS |
| Federica Conte, IASI-CNR of Rome, Italy | |
| 14:40 - 15:00 | Title: p38g integrates metabolic and immune signaling in breast tumorigenesis |
| Chen Guan, Medical College of Wisconsin, USA | |
| 15:00-15:20 | Title: Prevention of breast cancer relapses by oxidizing drugs and microRNA modulation |
| Alberto Izzott, University of Genoa, Italy | |
| 15:20-15:40 | Title: Antibiotic prophylaxis in breast surgery: a meta-analysis to identify the optimal strategy to reduce infection rates in breast surgery |
| Bader Nawaf Alali, Mubarak Al Kabeer Hospital, Ministry of Health, kuwait | |
| 15:40-16:00 | Title: Hormonally-dependent gene expression involving the Stat5a/HDAC6/HMGN2 complex undergoes dynamic regulation and is exploitable in ER+ breast cancer |
| Charles V. Clevenger, Virginia Commonwealth University, USA | |
| 16:00-16:10 | Refreshment Break |
| 16:10-16:30 | Title: New therapeutic approaches in the treatment of triple-negative breast cancer |
| Krisztina Kovacs, University of Pécs, Hungary | |
| 16:30-16:50 | Title: Cancer biomarker in white blood cells – An enlighten technology for cancer screening |
| Charoenchai P., Chulalongkorn University, Thailand | |
| 16:50-17:10 | Title: Metastatic Breast Cancer Presenting as Pulmonary Nodules and Right Axillary Lymph Node in a Male with Chronic Lymphocytic Leukemia |
| Jose Maria Acostamadiedo, University of Vermont, USA | |
| 17:10-17:20 | Title: Achillea fragrantissima (Forssk.) Sch.Bip flower dichloromethane extract exerts anti-proliferative and pro-apoptotic properties in human triple-negative breast cancer (MDA-MB-231) cells In vitro and in silico |
| Zeyad Ibrahim Alehaideb, King Abdullah International Medical Research Centre, Saudi Arabia | |
| 17:20-17:30 | Title: An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy |
| Pasquale Sibilio, Sapienza University of Rome, Italy | |
| Day 1 Concludes | |
day 2 agenda
| Day-2 (Sep-21, 2022) | |
| Virtual Presentations | |
| 08:00-08:20 | Title: Gene dosage analysis on the single-cell transcriptomes linking cotranslational protein targeting to metastatic triple-negative breast cancer |
| Min Zhao, University of the Sunshine Coast, Australia | |
| 08:20-08:40 | Title: Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in patients with breast cancer: Clinical advances and controversies |
| Junyuan Lv, The Affiliated Hospital of Zunyi Medical University, China | |
| 08:40-09:00 | Title: Mining immune-related genes with prognosticvalue in the tumor microenvironment of breastinvasive ductal carcinoma |
| Qiang He, Medical University, China | |
| 09:00-9:20 | Title: Risk Factors of Brain Metastasis and Prognosis in HER2-Positive Breast Cancer:A Single-Institutional Retrospective Analysis from China |
| Shuang-long Cai , Provincial Clinical Medical College of Fujian Medical University, China | |
| 09:20-09:40 | Title: A cooperation of CCR7 and CXCR4 ligand chemokines regulate breast cancer cell invasion and migration toward lymphatic vessels |
| Haruko Hayasaka, Kindai University, Japan | |
| 09:40-10:00 | Title: Spatially-resolved laser-activated cell sorting for breast cancer biomarker discovery |
| Amos Chungwon Lee, Seoul National University, south korea | |
| 10:00-10:20 | Title: Adding features from Mathematical model of breast cancer to improve the Algorithms of machine learning |
| OPhir Nave, Jerusalem College of Technology, Israel | |
| 10:20-10:40 | Title: A review of the endocrine resistance in hormone-positive breast cancer |
| Tsai-Ju Chien, National Yang-Ming Chiao Tung University, Taiwan | |
| 10:40-11:00 | Title: Hyperthermic intrathoracic chemotherapy for the treatment of malignant pleural effusion caused by breast and ovarian cancer: A systematic literature review and pooled analysis |
| Ioannis Karampinis, University of Mainz, Germany | |
| 11:00-11:20 | Title: Impact of doxorubicin on cell-substrate topology |
| Herbert Schneckenburger, Aalen University, Germany | |
| 11:20-11:40 | Title: Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein |
| Joanna Kopecka, University of Turin, Italy | |
| 11:40-12:00 | Title: SWIM: a network-based approach for human diseases |
| Paola Paci, Sapienza University of Rome, Italy | |
| 12:00-12:20 | Title: Breast cancer stem cell antigens as targets for immunotherapy and targeted therapies |
| Laura Conti, University of Turin, Italy | |
| 12:20-12:40 | Title: Preimplantation Genetic Testing for breast cancer |
| Oladapo, Medical Art Center Clinic, Nigeria | |
| 12:40-13:00 | Title: Transcription and translation regulation work together during a luminal to basal transition of breast cancer cells |
| Tamara Fernández-Calero, Universidad Católica del Uruguay/ Institut Pasteur de Montevideo, Uruguay | |
| 13:00-13:20 | Title: Targeting ectopic Hsp90 with PET enabled Hsp90 inhibitors to noninvasively detect and treat metastatic breast cancer |
| Timothy Haystead, Duke University, USA | |
| 13:20-13:40 | Title: Diagnostic Utility of TRPS1 Immunohistochemistry in Primary and Metastatic Breast Carcinoma with Special Emphasis on Spindle Cell Neoplasms of the Breas |
| Silvat Sheikh-Fayyaz, Donald and Barbara Zucker School of Medicine, USA | |
| 13:40-14:00 | Title: Impact of smoking cessation on survival of breast cancer patients |
| Kareem Seoudy, University of Virginia, USA | |
| 14:00-14:20 | Title: Tumor-Driving EGFR/K-RAS/SIAH Pathway Activation for Risk Stratifying Patients, Quantifying Therapy Efficacy, Detecting Cancer Disparity, Forecasting Tumor Relapse, and Predicting Patient Survival in Triple-Negative Breast Cancer |
| Amy H. Tang , Eastern Virginia Medical School, USA | |
| 14:20-14:40 | Title: Identification of distinct immune landscapes using multiplex immunofluorescence in paraffin tumor tissues |
| Edwin R. Parra, The University of Texas, USA | |
| 14:40-15:00 | Title: Incidental Breast Findings on Chest CT Studies |
| Cihan Duran, UT Houston Center, USA | |
| 15:00-15:20 | Title: Hybrid metabolic phenotype and mitochondria-nuclear crosstalk can regulate breast cancer progression |
| Benny Kaipparettu, Baylor College Of Medicine, USA | |
| 15:20-15:40 | Title: .Impact of using median vs. mean in calculating ERBB2 FISH results in breast cancer |
| Jianli Dong, University of Texas Medical Branch, USA | |
| 15:40-16:00 | Title: Steroid receptor co-activator complexes regulate breast cancer stem cell pathways to drive therapy resistant ER+ breast cancer |
| Julie Hanson Ostrander, University of Minnesota, USA | |
| 16:00-16:20 | Title: Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK–LKB1 Signaling Axis |
| Richard G Pestell, Baruch S Blumberg Institute, USA | |
| 16:20-16:40 | Title: Metabolic profiling and tracking phenotypic changes in mitochondria in cancer cells with Mitometer and the phasor approach to FLIM |
| Michelle Digman, University of California Irvine, USA | |
| 16:40-17:00 | Title: Src kinase/ CUB-domain containing protein 1/ protein kinase C delta pathway is active in a subset of triple-negative breast cancers and can be targeted |
| Olga Razorenova, University of California, USA | |
| TBA | |
| 16:40-17:00 | Closing Ceremony & Refreshment Break |
| Note: This is the tentative program only and the timings may be subject to change | |
| If any one interested to attend the conference or to book your speaker slot, please send an email to breastcancer@innovinc.org | |
| Conference Hotel: Hotel FrontAir Congress Barcelona, Carrer de les Alberedes, 16, 08830 Sant Boi de Llobregat, Barcelona, Spain |
|